PrivacyBrain was designed from the ground up to scale to meet the needs of the executives and employees safety. They automate the removal of exposed personal information. Their intuitive dashboard allows to view what personal information has been exposed and the progress of its removal. After removal they continue to scan data broker sites for newly exposed personal information and automatically requests its removal.
Simergent develops home dialysis devices for developed and emerging markets. The company was founded in 2014 and is based in Oklahoma City, OK and Chicago, Illinois, United States.
BPEndo is a company developing a medical device to assist physicians to conduct colonoscopies.
Progentec Diagnostics was set up to explore and commercialize state of the art diagnostic interventions in therapeutic areas with a high level of unmet need. The company is collaborating with a number of research institutions and individuals around the world engaged in bringing the latest technological innovations to the field of diagnostics. The commitment to this cause is firmly rooted in our belief that better diagnostics would not only help in better and less costly management of diseases, but also help tremendously in reducing the incidence of diseases through early screening and detection.
Named one of the most innovative companies by HousingWire Tech100 for the past two years, WHITEBOARD CRM is a CRM created for mortgage professionals by some of the industry's top producers. We're obsessed with helping LO's and branch managers build their teams and grow their businesses by creating better relationships with clients and referral partners.
SendaRide provides customized non-emergency medical transportation for the healthcare industry.
Raw Space For Rent is an online community marketplace that connects people looking to rent out their unused space with people looking for spaces to rent: artists, musicians, fashion shows, weddings, events, readings, car storage, pop-up shops, filmmakers, performance art, roller skating, meditation circles, workspace, cocktail parties or where ever your imagination takes you.
iRecommend Software™ develops intelligent business solutions utilizing artificial intelligence (AI), machine learning, and dynamic data modeling. In a consumer-driven economy, businesses across all industries, are facing the challenge to remain relevant and provide highly personalized products and services. iRecommend's leading solution, Recommendation360™ is a recommendation engine with applications across multiple industries, including recruiting, real estate, retail/e-commerce, entertainment, travel, government, and healthcare. These industry-specific solutions enable businesses to generate hyper-personalized recommendations of products and services for their customers. Recommendation360's proprietary technology rapidly aggregates and analyzes millions of data points from the public domain to provide the right products or services to the right person at the right time. Headquartered in Tulsa, Oklahoma with offices in Oklahoma City, New York, San Francisco, London, and Dubai.
Clear River Enviro is a U.S.-based company that manufactures and markets devices, which allow hospitals and nursing homes to dispose of their pharmaceutical waste safely and conveniently. The company was founded in 2009 and is based in Sugar Land, Texas.
Linear Health Sciences is a medical device company creating products for various types of medical tubing based on its proprietary, breakaway safety-valve technology. This platform technology is designed to improve the healthcare experience for patients, caregivers, and healthcare facilities. The company has made substantial progress toward global patent protections and FDA clearance for the Orchid Safety Release Valve. There is a total addressable market of more than $1 billion annually for devices made by the company, which was founded by a physician and two engineers.
Progentec Diagnostics was set up to explore and commercialize state of the art diagnostic interventions in therapeutic areas with a high level of unmet need. The company is collaborating with a number of research institutions and individuals around the world engaged in bringing the latest technological innovations to the field of diagnostics. The commitment to this cause is firmly rooted in our belief that better diagnostics would not only help in better and less costly management of diseases, but also help tremendously in reducing the incidence of diseases through early screening and detection.
MaxQ is a provider of insulated shipping containers for safe transportation of temperature sensitive goods.
Happily is an e-commerce company that ignites a relationship through activities for any couple at the click of a button.
Happily is a developer of a date-planning app that aims to help couples rediscover their date nights. The company's app provides gifting suggestions, monthly subscription boxes for couples, and date personalization, allowing users to have a new experience every month, spend quality time together, and create moments for couples to connect. In a fun and meaningful way, couples can continue to develop and connect in their relationships through using Happily.
WeGoLook is mobile technology company featuring a crowdsourced platform of 30,000+ "Lookers" nationwide to complete on-demand field services, including inspections and custom tasking. Our agents, known as "Lookers", collect field data, photos, and video via the WeGoLook mobile app and/or complete custom tasking, such as item pickup, delivery, document research and more. WeGoLook specializes in verifying autos, properties, boats, heavy equipment, antiques, electronics, furniture, RV’s and other assets. WeGoLook has expanded to international markets, including the United Kingdom, Canada, and Australia with other countries soon to follow. How it works: Companies or individuals engage with WeGoLook to order an on-site inspection report or custom task via WeGoLook’s web platform for autos, real estate, heavy equipment, courier services, notary services, and more. WeGoLook then dispatches an Agent within proximity of the location to complete the on-site inspection by collecting dynamic data, photos, and video utilizing the WeGoLook Mobile Application for iOS or Android. The report goes through quality assurance review and delivered to an insurance provider in their preferred format (API, .html, PDF, compressed images, and more).
Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. Its portfolio includes prototypic RecA inhibitors, which target various pathogenic bacteria/E. coli, including those responsible for lung, urinary tract, and skin infections, as well as weaponizable gram-positive and gram-negative pathogens through various bactericidal antibiotics. The company was incorporated in 2009 and is based in Chapel Hill, North Carolina.
Exaptive is an ecosystem for creating knowledge from data that enables developers and facilitating innovation through cognitive networks. The company uses software to make the process of organizing teams and communities easier and more productive. It builds tools that make collaborating on data and analysis fluid to make data and intuition to flow freely among the smart people working together to have an impact. Exaptive was established in 2011 and is headquartered in Oklahoma City, Oklahoma.
Moleculera Labs was founded by Drs. Craig Shimasaki and Madeleine Cunningham in 2011, to medically understand and clinically identify the underlying biological root of neurological, psychiatric, and behavioral disorders. Similar to the emergence of the immuno-oncology connection, epidemiological and research evidence demonstrates that a large portion of neuropsychiatric disorders are caused by an autoimmune dysfunction. The Company owns and operates a fully accredited clinical laboratory with its first revenue generating product—a blood panel called the Cunningham Panel™ that detects brain and nervous system targeted autoimmune antibodies in patients with neurologic, psychiatric, and behavioral disorders triggered by an infection. Patients are diagnosed with PANS, PANDAS, autism spectrum disorder, ADD/ADHD, bipolar disorder, anxiety disorder, Tourette’s, obsessive compulsive disorder (OCD), schizophrenia, or other neurologic and psychiatric syndromes, whereas the root may be a dysfunctional immune response. Symptoms include OCD, anxiety, depression, psychosis, motor or vocal tics, verbal and non-verbal communication difficulty, deteriorating social skills, eating disorders, academic regression, and rage. These patients are typically prescribed neuropsychiatric drugs, often resulting in little or no improvement. However, once a patient is correctly diagnosed through testing, treatment is redirected towards the immune system, neuroinflammation, and subclinical infections, resulting in remarkable recoveries, sometimes after decades of suffering. Moleculera is the sole clinical laboratory performing this panel covered by two U.S. patents. The Company has received and processed over 13,000 blood specimens ordered by over 1,700 physicians in over 50 countries, all prior to launching a sales force. The Company generated $1.1 MM in 2021 and is preparing to scale for revenue expansion with expectations of revenue ~$25 MM in 4-5 years. The company is now applying this technology to autoimmune cardiovascular disease and Long-COVID symptoms. The basic research that led to the identification of these antineuronal antibody targets was studied for over 20 years in the laboratory of Dr. Madeleine Cunningham at The University of Oklahoma Health Sciences Center, with subsequent collaboration from the Pediatric Branch of the National Institutes of Mental Health (NIMH). Scientific and clinical results have been published in multiple top-tier peer-reviewed journals. Certain infections that have been found to trigger these autoimmune antibodies include strep, Lyme, mycoplasma, Babesia, bartonella, coxsackie virus, and others. Medical journals have reported an autoimmune response to SARS-CoV-2 (COVID-19), with approximately one-third of patients experiencing some neurologic or psychiatric symptoms. The patented Cunningham Panel™ consists of five tests. Four which measure levels of autoantibodies directed against Dopamine D1 receptor, Dopamine D2L receptor, Lysoganglioside GM1, and Tubulin. A fifth test measures CaM Kinase II activation, a key enzyme involved in the production of neurotransmitters dopamine, epinephrine, and norepinephrine. Autoimmune antibodies that bind to these targets interfere with or block normal neurologic activity in the brain and nervous system. The laboratory results assist a physician in making a diagnosis and identifying the appropriate therapy. In addition to individual clinicians who order the panel, the Company has provided testing to over 80 medical institution customers. In a 2020 publication in the Journal of Neuroimmunology, the Cunningham Panel demonstrated an 88% sensitivity and 92% specificity with an accuracy of 90% correlating these autoantibody elevations and neuropsychiatric symptoms before and after treatment. The Cunningham Panel aids a clinician’s treatment decision by directing them to the underlying subclinical infections and neuroimmune dysfunction, rather than simply treating symptoms. Effective treatments typically include various anti-infectives, anti-inflammatory agents and immunomodulators. Moleculera' s Test Panel generates an average realized revenue of $900 through existing CPT codes and patient billing. The Company has generated over $10 million in cumulative revenue since opening. During the COVID-19 pandemic, revenues for 2021 were $1.1 million, all prior to adding a sales force. Approximately 10% of orders come from a growing international market, with the Company receiving orders from over 1,700 clinicians. Moleculera Labs has one of the largest IRB approved and clinically annotated serum specimen biobanks of over 13,000 specimens utilized for research and development of new products for autoimmune neuropsychiatric disorders. The Company has demonstrated its panel’s clinical utility in multiple neuropsychiatric disorders and have been able to predict treatment efficacy while working with pharmaceutical and research partners to assist in identifying novel drug targets. There is a clear unmet medical need and demand in this $23 billion dollar neuropsychiatric and behavioral disorder market. Moleculera recently in-licensed exclusive technology for multiple autoimmune antibody targets against the heart, which are implicated in a portion of multiple cardiovascular diseases such as heart failure, cardiomyopathy, atrial fibrillation, and myocarditis. With this technology along with proposed clinical studies and validation in process, the Company expects to develop and commercialize two additional panels. One panel will target various cardiovascular diseases (world-wide market of $4.9 trillion) infection-triggered autoimmunity, and another panel for diagnosing and treatment-monitoring of Long-COVID (estimated at $6.5 trillion). Our precision medicine business model is fashioned after Foundation Medicine and Genomic Health, whose precision medicine companies were acquired by Roche in 2018 for $5.3 billion, and Exact Sciences in 2019 for $2.8 billion, respectively. Moleculera Labs is led by Dr. Craig Shimasaki, a serial entrepreneur with over 35 years of biotechnology experience, who began his career at Genentech. He co-founded multiple companies, participated in taking several companies public into the U.S. and the Canadian stock exchange, led five products through the FDA diagnostic approval process, and has directed two CLIA labs, raising over $30 million for these companies. Dr. Madeleine Cunningham, Chief Scientific Officer, is an internationally recognized leader in infection-induced autoimmune neuropsychiatric disorders and is a tenured professor at the University of Oklahoma with over 40 years of research and over 130 authored publications in leading scientific and medical journals. Dr. James Appleman is VP of R&D and Clinical Development and has 30+ years’ experience in building successful diagnostic and therapeutic companies from inception through successful exits, including a $230M exit to Roche. Mr. Fred Hiller is CFO and brings 45+ years’ experience in corporate finance and accounting. He began his career at Touche Ross & Co. in 1962, serving as controller at Elgin National and Columbia Pictures, and CFO at Wilkinson Sword. He has been a financial consultant to numerous companies including two biotechnology companies and one that was publicly traded.
Associated Material Processing manufactures proprietary, low-cost media for the complete removal of arsenic from industrial or manufacturing process waste and drinking water. Arsenic contamination in semiconductor manufacture, processed foods, and drinking water is a large and growing problem worldwide. Its chemical compounds remove hazardous and unwanted chemicals from waste streams of semiconductors that enable manufacturers to offer purified water.
Valve Systems International has developed a control valve particularly suited to regulating the flow of fluid between a high-pressure source and low-pressure discharge volume, which increases reliability and lowers operating costs by reducing maintenance and repair requirements.
WeGoLook is mobile technology company featuring a crowdsourced platform of 30,000+ "Lookers" nationwide to complete on-demand field services, including inspections and custom tasking. Our agents, known as "Lookers", collect field data, photos, and video via the WeGoLook mobile app and/or complete custom tasking, such as item pickup, delivery, document research and more. WeGoLook specializes in verifying autos, properties, boats, heavy equipment, antiques, electronics, furniture, RV’s and other assets. WeGoLook has expanded to international markets, including the United Kingdom, Canada, and Australia with other countries soon to follow. How it works: Companies or individuals engage with WeGoLook to order an on-site inspection report or custom task via WeGoLook’s web platform for autos, real estate, heavy equipment, courier services, notary services, and more. WeGoLook then dispatches an Agent within proximity of the location to complete the on-site inspection by collecting dynamic data, photos, and video utilizing the WeGoLook Mobile Application for iOS or Android. The report goes through quality assurance review and delivered to an insurance provider in their preferred format (API, .html, PDF, compressed images, and more).
Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. Its portfolio includes prototypic RecA inhibitors, which target various pathogenic bacteria/E. coli, including those responsible for lung, urinary tract, and skin infections, as well as weaponizable gram-positive and gram-negative pathogens through various bactericidal antibiotics. The company was incorporated in 2009 and is based in Chapel Hill, North Carolina.
Roll-2-Roll Technologies LLC is a start-up company located in Stillwater, OK. We are an Oklahoma State University (OSU) spin-off commercializing an electro-mechanical device called a lateral guide for roll-to-roll manufacturing applications. This device will save manufacturers time and money by reducing downtime and wastage in their manufacturing process.
Developer of an unified monitoring platform designed to provide oil and gas well site production, safety and security. The company's unified monitoring platform offers video monitoring, reporting, alerting and video data storage and retrieval through a proprietary, patent-pending, internet-based software, enabling businesses to reduce the expense and personnel costs to monitor well sites, as well as prevents damage and loss of equipment.
Monscierge is an international software company specializing in innovative hospitality solutions. Since 2009, our global team has been developing a system called Connect to facilitate elegant connections between the guest, hotel properties and their brands. Connect solutions encompass modern platforms such as mobile, tablet, large-format touchscreen devices and a central web-based platform to manage all content. We have also developed custom solutions to address specific needs. With installations around the world, Monscierge is dedicated to improving guest experiences and hotel staff efficiency around the world by facilitating an experience that will inspire customer loyalty.
Otologic Pharmaceutics, Inc. is a company committed to developing treatments for acute hearing loss to reduce the development of permanent hearing disorders. OPI’s lead program HPN1010, an oral medication to treat acute hearing loss, will enter clinical trials in 2014. Initial research focuses on Noise Induced Hearing Loss. We will continue to work to expand the applicability of HPN1010 to treat hearing loss from other causes, such as Cisplatin Induced Hearing loss.
Miira Artist Tools is a versatile tool designed for the professional artists, designers, and beginners.
The Mantis VR glove. The first affordable consumer-level wireless virtual-reality glove
SmartPanel is developing an innovative new home energy management product to be mounted on the circuit breaker of homes and small commercial buildings. Whereas competing technologies focus on controlling power at switches and plugs, Smart Panel takes a holistic view of the home and controls energy distribution at the natural energy hub. By placing a single device at the breaker, the homeowner achieves control with a single affordable device.
EQUIP Advantage provides immediate access to the oil and gas industry’s equipment at the right time.
SIVI's core product is LaunchLeader, the micro-crowdfunding platform for entrepreneurs to rally supporters and raise startup money for their prototypes (MVPs). The unique fundraising design is set up like a wedding registry wish list so donors can back specific startup tools, e.g. video, logo, social media ads. LaunchLeader is positioned as a pre-Kickstarter/Indiegogo or pre-accelerator crowdfunding platform when friends and family are your main supporters. LaunchLeader's parent company, SIVI, is a virtual incubator started by successful founders dedicated to democratizing entrepreneurship.
Tetherex Pharmaceuticals operates in the healthcare industry focusing on biotechnology business. The company was incorporated in 2014 and is based in Oklahoma City, Oklahoma.
4DSales is an evolutionary tablet-based mobile sales application. They also offer increase company revenue performance, increase sales performance, sales tools to increase revenue, mobile sales applications, and sales performance services.
Tailwind is a leading small business marketing platform that helps entrepreneurs, creators, sellers and marketers plan, create and execute world-class marketing campaigns across digital marketing platforms including Email marketing, Facebook, Instagram and Pinterest. Tailwind is rapidly shifting the status quo that marketers should expect from marketing software by integrating what would normally be separate stand alone tools into one cohesive system, with the goal of enabling small businesses to become effective omni-channel marketers within their unique needs.
Moleculera Labs was founded by Drs. Craig Shimasaki and Madeleine Cunningham in 2011, to medically understand and clinically identify the underlying biological root of neurological, psychiatric, and behavioral disorders. Similar to the emergence of the immuno-oncology connection, epidemiological and research evidence demonstrates that a large portion of neuropsychiatric disorders are caused by an autoimmune dysfunction. The Company owns and operates a fully accredited clinical laboratory with its first revenue generating product—a blood panel called the Cunningham Panel™ that detects brain and nervous system targeted autoimmune antibodies in patients with neurologic, psychiatric, and behavioral disorders triggered by an infection. Patients are diagnosed with PANS, PANDAS, autism spectrum disorder, ADD/ADHD, bipolar disorder, anxiety disorder, Tourette’s, obsessive compulsive disorder (OCD), schizophrenia, or other neurologic and psychiatric syndromes, whereas the root may be a dysfunctional immune response. Symptoms include OCD, anxiety, depression, psychosis, motor or vocal tics, verbal and non-verbal communication difficulty, deteriorating social skills, eating disorders, academic regression, and rage. These patients are typically prescribed neuropsychiatric drugs, often resulting in little or no improvement. However, once a patient is correctly diagnosed through testing, treatment is redirected towards the immune system, neuroinflammation, and subclinical infections, resulting in remarkable recoveries, sometimes after decades of suffering. Moleculera is the sole clinical laboratory performing this panel covered by two U.S. patents. The Company has received and processed over 13,000 blood specimens ordered by over 1,700 physicians in over 50 countries, all prior to launching a sales force. The Company generated $1.1 MM in 2021 and is preparing to scale for revenue expansion with expectations of revenue ~$25 MM in 4-5 years. The company is now applying this technology to autoimmune cardiovascular disease and Long-COVID symptoms. The basic research that led to the identification of these antineuronal antibody targets was studied for over 20 years in the laboratory of Dr. Madeleine Cunningham at The University of Oklahoma Health Sciences Center, with subsequent collaboration from the Pediatric Branch of the National Institutes of Mental Health (NIMH). Scientific and clinical results have been published in multiple top-tier peer-reviewed journals. Certain infections that have been found to trigger these autoimmune antibodies include strep, Lyme, mycoplasma, Babesia, bartonella, coxsackie virus, and others. Medical journals have reported an autoimmune response to SARS-CoV-2 (COVID-19), with approximately one-third of patients experiencing some neurologic or psychiatric symptoms. The patented Cunningham Panel™ consists of five tests. Four which measure levels of autoantibodies directed against Dopamine D1 receptor, Dopamine D2L receptor, Lysoganglioside GM1, and Tubulin. A fifth test measures CaM Kinase II activation, a key enzyme involved in the production of neurotransmitters dopamine, epinephrine, and norepinephrine. Autoimmune antibodies that bind to these targets interfere with or block normal neurologic activity in the brain and nervous system. The laboratory results assist a physician in making a diagnosis and identifying the appropriate therapy. In addition to individual clinicians who order the panel, the Company has provided testing to over 80 medical institution customers. In a 2020 publication in the Journal of Neuroimmunology, the Cunningham Panel demonstrated an 88% sensitivity and 92% specificity with an accuracy of 90% correlating these autoantibody elevations and neuropsychiatric symptoms before and after treatment. The Cunningham Panel aids a clinician’s treatment decision by directing them to the underlying subclinical infections and neuroimmune dysfunction, rather than simply treating symptoms. Effective treatments typically include various anti-infectives, anti-inflammatory agents and immunomodulators. Moleculera' s Test Panel generates an average realized revenue of $900 through existing CPT codes and patient billing. The Company has generated over $10 million in cumulative revenue since opening. During the COVID-19 pandemic, revenues for 2021 were $1.1 million, all prior to adding a sales force. Approximately 10% of orders come from a growing international market, with the Company receiving orders from over 1,700 clinicians. Moleculera Labs has one of the largest IRB approved and clinically annotated serum specimen biobanks of over 13,000 specimens utilized for research and development of new products for autoimmune neuropsychiatric disorders. The Company has demonstrated its panel’s clinical utility in multiple neuropsychiatric disorders and have been able to predict treatment efficacy while working with pharmaceutical and research partners to assist in identifying novel drug targets. There is a clear unmet medical need and demand in this $23 billion dollar neuropsychiatric and behavioral disorder market. Moleculera recently in-licensed exclusive technology for multiple autoimmune antibody targets against the heart, which are implicated in a portion of multiple cardiovascular diseases such as heart failure, cardiomyopathy, atrial fibrillation, and myocarditis. With this technology along with proposed clinical studies and validation in process, the Company expects to develop and commercialize two additional panels. One panel will target various cardiovascular diseases (world-wide market of $4.9 trillion) infection-triggered autoimmunity, and another panel for diagnosing and treatment-monitoring of Long-COVID (estimated at $6.5 trillion). Our precision medicine business model is fashioned after Foundation Medicine and Genomic Health, whose precision medicine companies were acquired by Roche in 2018 for $5.3 billion, and Exact Sciences in 2019 for $2.8 billion, respectively. Moleculera Labs is led by Dr. Craig Shimasaki, a serial entrepreneur with over 35 years of biotechnology experience, who began his career at Genentech. He co-founded multiple companies, participated in taking several companies public into the U.S. and the Canadian stock exchange, led five products through the FDA diagnostic approval process, and has directed two CLIA labs, raising over $30 million for these companies. Dr. Madeleine Cunningham, Chief Scientific Officer, is an internationally recognized leader in infection-induced autoimmune neuropsychiatric disorders and is a tenured professor at the University of Oklahoma with over 40 years of research and over 130 authored publications in leading scientific and medical journals. Dr. James Appleman is VP of R&D and Clinical Development and has 30+ years’ experience in building successful diagnostic and therapeutic companies from inception through successful exits, including a $230M exit to Roche. Mr. Fred Hiller is CFO and brings 45+ years’ experience in corporate finance and accounting. He began his career at Touche Ross & Co. in 1962, serving as controller at Elgin National and Columbia Pictures, and CFO at Wilkinson Sword. He has been a financial consultant to numerous companies including two biotechnology companies and one that was publicly traded.
codesy is an open source market that matches coders to valuable software bugs in a pay-what-you-want, make-what-you-want system. Git Logo by Jason Long is licensed under the Creative Commons Attribution 3.0 Unported License.
Synercon Technologies is new venture that offers technology that extracts digital data from heavy-trucks and buses that have been in a crash in a forensically sound manner. Current strategies are cumbersome, spoil forensic data, and not employed in as many cases as they could. The Synercon system uses a custom hardware and software approach to preserve data that is already stored in the vehicle.
We make fun educational. At Tempered Mind, we focus on education that’s both fun and mobile. We build it so you can bring it with you. By combining the fantastic power of contemporary mobile technology, popular mobile gaming formats, and tried-and-true teaching methods, we provide our users with a truly unique educational experience.
Offerboxx is a location based marketing software that makes it possible for businesses to collect rich information from consumers on-site and in an engaging way. Offerboxx makes that data available instantly and in a way that measures the results of each campaign.
Drik is an Oklahoma City-based provider of toxicology services for companies developing new drugs. Led by Kumar Sripathirathan, founder and CEO, Drik provides customized testing which help researchers and pharmaceutical companies identify toxicology requirements and the safety of new drugs under development.
Sway Medical, LLC is a Texas-based company founded in 2011 that specializes in the development of medical-grade mobile applications for monitoring patient outcomes in orthopedics, geriatrics, and pharmacology. The company's flagship product, Sway Balance, is an FDA-cleared application that utilizes patent-pending motion analysis protocols to assess balance and detect instability, particularly following head injuries. This mobile software enables healthcare professionals, sports coaches, and individuals to conduct objective tests on balance, reaction time, and cognitive function in various settings, including physical therapy clinics, senior living facilities, and sports environments. By providing quantifiable data, Sway Medical's technology enhances the ability to monitor and manage musculoskeletal, neurological, and vestibular dysfunction effectively.
ICEdot, a Tulsa, Oklahoma-based developer of a crash sensor attached to the safety helmet of sportsmen. Led by Chris Zenthoefer, CEO, ICEdot has developed a crash sensor attached to the safety helmet of cyclists, skiers, snow boarders, BMX bikers and other action sport participants to detect forces consistent with head injury and notify predesignated health and geolocation information over sms/text.
The Campaign Solution optimizes candidates’ time and resources. It was founded by Dan Mazzei in 2010.
Your residents practically live on their phones. ReTenant builds you your very own app, so you can build better communication, better service and better community. Over 70% of all apartment properties still use paper fliers to communicate important messages. Communication is what builds relationships — so imagine what kind of relationships these really are. Your app will allow you to replace paper, portals, emails and smoke signals on day one. Residents sound off much more frequently on their phones. Your app makes it super convenient for your residents to communicate problems and make suggestions. You will know what is wrong instantly, coordinate and communicate fixes seamlessly, and take care of problems faster — delighting your residents.
PolySkope Labs was founded by pioneers in the field of clinical molecular diagnostics and multiplex assay development. PolySkope has completed the development and validation of the first comprehensive, modular, multiplex assay for the simultaneous detection of 1, 2, or 3 of the most common foodborne pathogens. This revolutionary technology provides >3 fold reductions in the cost-of-analysis for food safety labs.
Medefy is a healthcare app that lets employers directly connect with their employees about their health benefits. It allows employers to communicate and engage with employees to prompt better healthcare decisions and allows employees to shop for better-priced, higher-quality healthcare providers in their area. Medefy was founded in 2018 and is based in Tulsa, Oklahoma.
Docvia is a privately held software venture that provides secure, HIPAA-compliant electronic access between established patients and their health providers. The company's software was first commercially deployed at St. John Health System in Tulsa, Oklahoma. The Docvia team is comprised of practicing physicians, software engineers and designers that work together with community leaders in order to provide safe, simple and inexpensive health access around the world.
EmpowrNet will offer a mobile application that supports consumers, their family members and their friends in their collective effort to manage the array of long term care services and supports required to safely live at home and avoid nursing home care. Nine of ten individuals age 50+ want to age in place - to live at home as independently as possible as long as possible and avoid nursing home placement. For both consumers and family members the primary concern related to supporting aging in place is retaining the control over their lives they had before the need for long term care services entered the picture. EmpolwrNet's communication tool will give consumers and their families the opportunity to retain control of their lives by gives them the tools to successfully manage the challenges of aging in place.
Expert TA enables Professors and Teaching Assistants to focus their time on educating your students. Leave the homework grading to the computer, complete with partial credit grading of the most complex of math and physics problems.
Perk Dynamics™, LLC is a software development company dedicated to increasing the efficiency of coffee and espresso drink operations. We are focused on improving the process and quality of brewed beverage order flows to increase profits, ROI, and customer satisfaction in establishments that serve coffee, tea and other machine produced beverages. With the release of AutoPerk the Automated Barista; Casinos, Resorts, Hotels, Hospitals can now enjoy the high profits of an automated coffee shop that delivers consistent quality Barista Quality Beverages 24/7/365.
DermaMedics is a pharmaceutical skin care company specializing in the development of novel topical therapeutics for the dermatology market. DermaMedics has broad expertise in skin research, drug discovery, and topical product formulation. The company is using this expertise to identify novel phytochemicals that can gently and effectively treat inflammatory skin problems and skin aging without the side effects associated with topical corticosteroids and immunosuppressive drugs. DermaMedics’ research has led to the discovery of Therosol®, a botanically-derived chemical compound with remarkable anti-inflammatory and anti-aging activities. Clinical studies have shown that topical Therosol® is effective in treating psoriasis, eczema, acne, and rosacea, and can completely prevent radiation burns in cancer patients.
OMRF is the Oklahoma Medical Research Foundation. We are dedicated to fighting Alzheimer’s, heart disease, lupus, MS, cancer and other devastating illnesses.
Alkami Technology provides cloud-based digital banking solutions for credit unions and banks. Its platform provides financial institutions a complete digital banking solution ready to facilitate both retail and business user onboarding, engagement, and account servicing. It enables clients to enhance the platform with upgrades and can tailor their experience with additional Alkami products as well as third-party solutions. The company was founded in 2009 and is headquartered in Plano, Texas.
Grocio is a grocery data platform with several product lines: - Grocery comparison shopping - Real-time grocery pricing - Coupon matching to grocery list - Mobile tools for shoppers and grocers
Exerbotics designs advanced technology equipment and devices for commercial fitness applications. Exerbotics build products that, through technology, improve healthy living and quality of life. Their products track capability, monitor activity and deliver a documented history of actual work versus prescribed work.
Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that is developing drugs to treat inflammatory and thrombotic diseases. They are targeting the underlying disease mechanism for these disorders. Their target is the adhesion of white blood cells to sites of inflammation mediated by the binding of two proteins, P-selectin and PSGL-1. The company is in preclinical development of humanized antibodies to P-selectin and PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic disorders. Unregulated inflammatory processes play a major role in the harmful effects of multiple inflammatory disorders.
mobiManage is a leader in developing Mobile Web Solutions for businesses. mobiManage’s vision is simple: to build the best mobile solutions on the planet and give their clients the tools to engage their visitors, guests and customers. mobiManage is a true adaptive mobile technology company focused on building an open platform that integrates into any existing website, CMS, CRM or database. They ensure their clients have unique and engaging mobile products that integrate into a comprehensive mobile marketing platform; providing businesses with leading, cutting-edge mobile technology and marketing tools for easy and quick integration into marketing campaigns and strategies. mobiManage builds award-winning, engaging mobile solutions that harmonize with existing websites and marketing programs; all compatible with iOS Apple products, all Android platforms, Windows and Blackberry. Having designed over 400 custom mobile websites and applications, mobiManage provides businesses with custom design and easy integration with CRM/CMS systems; all with the freedom and flexibility needed for growing businesses. Utilizing mobiManage’s mobiPlatform clients can deploy, manage and support all mobile products allowing for easy real-time changes. Integrated in the platform are a series of marketing tools including mobile advertising, surveys, GEO location, SMS and more. mobiManage offers integrated responsive server-side website design, kiosk solutions with turnkey interactive solutions utilizing Word Press, Joomla, Microsoft and others. They offer free estimates/proposals.
Lifetone Technology develops and markets lifesaving alarming devices. It offers bedside fire alarms and clocks that protect against residential fires; and a bed shaker, which produces strong and intermittent vibration. The company sells its products online, as well as through dealers to children, heavy sleepers, seniors, and people with hearing loss in the United States. Lifetone Technology was formerly known as InnovAlarm Corporation and changed its name to Lifetone Technology in 2008. The company was founded in 2004 and is based in Oklahoma City, Oklahoma with additional offices in Chicago.
CreditPoint Software is a SaaS platform that offers B2B credit risk and collections management solutions. It offers online credit app, ratings and financial data, bureau integration, configurable scoring models, rule-based workflows, analytics-driven monitoring and alerts, and business intelligence. The platform aims to empower companies to be efficient and eliminate their credit and collections management challenges. From SME's to Fortune 500 companies, CreditPoint Software stands as a proven solution for businesses seeking to transform their credit and collections management. The Owasso, Oklahoma-located company was founded in 2000.